Docoh
Loading...

ZYXI Zynex

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex also has a blood volume monitor for use in hospitals and surgery centers.

Company profile

Ticker
ZYXI
Exchange
Website
CEO
Thomas Sandgaard
Employees
Incorporated
Location
Fiscal year end
Former names
ARIZONA VENTURES INC, CHINA GLOBAL DEVELOPMENT INC, FOX RIVER HOLDINGS INC, IBONZAI COM INC, LIFE MEDICAL TECHNOLOGIES INC /UT/, ZYNEX MEDICAL HOLDINGS INC, ZYNEX MEDICAL HOLDINGS INC
SEC CIK
IRS number
870403828

ZYXI stock data

(
)

Calendar

29 Jul 21
2 Aug 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Zynex earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
29 Jul 21 Anna Lucsok Common Stock (Restricted Stock Award) Grant Aquire A No No 0 1,642 0 62,343
29 Jul 21 Sandgaard Thomas Common Stock (Restricted Stock Award) Grant Aquire A No No 0 4,106 0 5,860
29 Jul 21 Daniel J Moorhead Common Stock (Restricted Stock Award) Grant Aquire A No No 0 4,106 0 96,393
27 Jul 21 Anna Lucsok Common Stock (Restricted Stock Award) Grant Aquire A No No 0 5,000 0 60,000
27 Jul 21 Anna Lucsok Common Stock (Restricted Stock Award) Grant Aquire A No No 0 5,000 0 60,701

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

35.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 119 125 -4.8%
Opened positions 18 21 -14.3%
Closed positions 24 33 -27.3%
Increased positions 40 41 -2.4%
Reduced positions 42 41 +2.4%
13F shares
Current Prev Q Change
Total value 241.94M 235.07M +2.9%
Total shares 12.18M 13.44M -9.4%
Total puts 176.4K 436.5K -59.6%
Total calls 250.3K 417.6K -40.1%
Total put/call ratio 0.7 1.0 -32.6%
Largest owners
Shares Value Change
BLK Blackrock 3.09M $47.17M +6.5%
Sandgaard Thomas 1.3M $17.02M 0.0%
Vanguard 1.24M $18.96M +12.0%
STT State Street 518.4K $7.92M +0.5%
Punch & Associates Investment Management 481.54K $7.35M +11.8%
Geode Capital Management 325.74K $4.97M +9.1%
Millennium Management 299.4K $4.57M +12.2%
NTRS Northern Trust 243.12K $3.71M -2.3%
Susquehanna International 235.82K $3.6M -6.2%
Capital Impact Advisors 226.92K $3.47M -17.6%
Largest transactions
Shares Bought/sold Change
Hood River Capital Management 0 -1.14M EXIT
Nuveen Asset Management 70.67K -246.65K -77.7%
GS Goldman Sachs 11.72K -242.92K -95.4%
Tygh Capital Management 223.2K +223.2K NEW
BLK Blackrock 3.09M +188.83K +6.5%
Vanguard 1.24M +132.77K +12.0%
Charles Schwab Investment Management 47.11K -112.51K -70.5%
WFC Wells Fargo & Co. 173.04K +109.48K +172.2%
Voloridge Investment Management 0 -83.05K EXIT
Janney Montgomery Scott 72.73K +72.73K NEW
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
Removed: drove, filing